Tumor-infiltrating lymphocytes for melanoma immunotherapy

Oliver Kepp; Peng Liu; Laurence Zitvogel; Guido Guido Kroemer

doi:10.1080/2162402x.2023.2175506

Related publications

Article2013

Tumor-Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis

Tobias Schatton, Richard A Scolyer, John F. Thompson, Martín C. Mihm

Letter2010

Tumor-infiltrating lymphocytes and mitotic index in metastatic melanoma as predictors of patient survival

Rajmohan Murali, Richard A Scolyer

Article2022

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

Thazin Nwe Aung, Saba Shafi, James S. Wilmott, Saeed Nourmohammadi, Ioannis Vathiotis, Niki Gavrielatou, Aileen I. Fernandez, Vesal Yaghoobi, Tobias Sinnberg, Teresa Amaral, Kristian Ikenberg, Kiarash Khosrotehrani, Iman Osman, Balázs Ács, Yalai Bai, Sandra Martínez-Morilla, Myrto Moutafi, John F. Thompson, Richard A Scolyer, David L. Rimm

Article2015

PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients

Hojabr Kakavand, James S. Wilmott, Alexander M. Menzies, Ricardo E. Vilain, Lauren E. Haydu, Jennifer H. Yearley, John F. Thompson, Richard Kefford, Peter Hersey, Georgina V. Long, Richard A Scolyer

Preprint2023

Data from PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients

Hojabr Kakavand, James S. Wilmott, Alexander M. Menzies, Ricardo E. Vilain, Lauren E. Haydu, Jennifer H. Yearley, John F. Thompson, Richard F. Kefford, Peter Hersey, Georgina V. Long, Richard A Scolyer